Evidence map›Paper›PMID 27264173›Full record

ArticleCell reports2016

The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.

Callie A S Corsa, Audrey Brenot, Whitney R Grither, Samantha Van Hove, Andrew J Loza, Kun Zhang, Suzanne M Ponik, Yuming Liu, David G DeNardo, Kevin W Eliceiri and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. The Duality of Collagens in Metastases of Solid Tumors.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. The fibroinflammatory response in cancer.Nature reviews. Cancer · 2025
    Review
  10. Article
  11. Discoid Domain Receptors Signaling in Macrophages-Mediated Diseases.International journal of general medicine · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Callie A S CorsaICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA.
Audrey BrenotICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA.
Whitney R GritherICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA; Department of Biochemistry, Washington University, St. Louis, MO 63110, USA.
Samantha Van HoveICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA.
Andrew J LozaICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA; Department of Computational and Molecular Biophysics, Washington University, St. Louis, MO 63110, USA.
Kun ZhangICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA.
Suzanne M PonikDepartment of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Yuming LiuLaboratory for Optical and Computational Imaging, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
David G DeNardoICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA.
Kevin W EliceiriLaboratory for Optical and Computational Imaging, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Patricia J KeelyDepartment of Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA; Laboratory for Optical and Computational Imaging, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.
Gregory D LongmoreICCE Institute, Washington University, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110, USA; Department of Medicine, Washington University, St. Louis, MO 63110, USA. Electronic address: glongmore@wustl.edu.
Washington University in St. Louis · USUniversity of Wisconsin–Madison · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic CancerR01CA177670 · NCI · WASHINGTON UNIVERSITY · PI DENARDO, DAVID G · 2014 to 2023
$3.3M
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASISR01CA196205 · NCI · WASHINGTON UNIVERSITY · PI LONGMORE, GREGORY D. · 2015 to 2019
$1.7M
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPYR01CA203890 · NCI · WASHINGTON UNIVERSITY · PI DENARDO, DAVID G · 2016 to 2020
$1.7M
INTERDISCIPLINARY TRAINING IN MECHANOBIOLOGY FROM NM TO CMT32EB018266 · NIBIB · WASHINGTON UNIVERSITY · PI BAYLY, PHILIP V · 2014 to 2018
$987k
Regulation of Snail1 in cancer metastasisF31CA165729 · NCI · WASHINGTON UNIVERSITY · PI CORSA, CALLIE ANN SPRUNGER · 2012 to 2014
$92k
NCI NIH HHS F31 CA165729NCI NIH HHS R01 CA177670NCI NIH HHS R01 CA196205NCI NIH HHS R01 CA203890NCI NIH HHS T32 CA113275NIBIB NIH HHS T32 EB018266NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

High levels of collagen deposition in human and mouse breast tumors are associated with poor outcome due to increased local invasion and distant metastases. Using a genetic approach, we show that, in mice, the action of the fibrillar collagen receptor discoidin domain receptor 2 (DDR2) in both tumor and tumor-stromal cells is critical for breast cancer metastasis yet does not affect primary tumor growth. In tumor cells, DDR2 in basal epithelial cells regulates the collective invasion of tumor organoids. In stromal cancer-associated fibroblasts (CAFs), DDR2 is critical for extracellular matrix production and the organization of collagen fibers. The action of DDR2 in CAFs also enhances tumor cell collective invasion through a pathway distinct from the tumor-cell-intrinsic function of DDR2. This work identifies DDR2 as a potential therapeutic target that controls breast cancer metastases through its action in both tumor cells and tumor-stromal cells at the primary tumor site.

Indexed as

AllelesAnimalsBreast NeoplasmsCancer-Associated FibroblastsCell Line, TumorCell MovementCell ProliferationDiscoidin Domain Receptor 2Disease ProgressionEpithelial CellsExtracellular MatrixFemaleGene DeletionHumansKeratin-14Lung NeoplasmsDiscoidin Domain Receptor 2Keratin-14

Identifiers

PMID27264173
PMCPMC4909540
OpenAlexW2415559729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.